John Carroll explains in this post on FieceBiotech that lately overseas regulators have been tightening their grasp of clinical trials around the world. Polish investigators want to know why two seniors died when they took two experimental bird flu vaccines developed by Novartis, and this is just one case of the tight regulations being put in place.
There is a growing concern that in the developing countries, the citizens are being used to test new drugs which will later be sold to more affluent markets. The Wall Street Journal estimates that roughly 40 percent of all clinical trials take place in lower-income countries.
Read the entire article in the Wall Street Journal
Search This Blog
Blog Archive
-
▼
2008
(97)
-
▼
December
(11)
- Happy Holidays from CROs
- Outsourcing to India
- Partnerships with CROs: Best of 2008
- CRO PharmaNet Development Group Explores Strategic...
- Keep Clinical Trial Participants in the Loop
- Child Death Rate in Outsourced Clinical Trials in ...
- Tigermed Consulting Announces OCT as a Partner in ...
- Thermal Fisher Opens up New Facility in India
- Bilcare Boosts its Clinical Trial Business in India
- Regulatory Changes in India
- Clinical Trial Regulations Grow Tighter Overseas
-
▼
December
(11)
No comments:
Post a Comment